Sporozoite immunization: innovative translational science to support the fight against malaria
Thomas L. Richie(Sanaria), Stephen L. Hoffman(University of Maryland, Baltimore), Mahamadou S. Sissoko(Université des Sciences, des Techniques et des Technologies de Bamako), Said Jongo(Ifakara Health Institute), Alassane Dicko(University of Bamako), Melissa C. Kapulu(Kenya Medical Research Institute), María-Silvia A. López Mikue(Government of Equatorial Guinea), Martina Oneko(Kenya Medical Research Institute), Natasha KC(Sanaria), Stefan H. I. Kappe(Center for Infectious Disease Research), Matthew B. Laurens(University of Maryland, Baltimore), Tooba Murshedkar(Sanaria), Andrea Kreidenweiss(Universitätsklinikum Tübingen), Halimatou Diawara(Université des Sciences, des Techniques et des Technologies de Bamako), James G. Kublin(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Issaka Sagara, David Dolberg(Sanaria), Matthew B. B. McCall(Radboud University Nijmegen), Ally Olotu(Ifakara Health Institute), Blandine Franke‐Fayard(Leiden University Medical Center), L. W. Preston Church(Sanaria), Sodiomon B. Sirima(Centre National de Recherche et de Formation sur le Paludisme), Laura C. Steinhardt(Centers for Disease Control and Prevention), Peter G. Kremsner(Albert Schweitzer Hospital), Judith E. Epstein(National Institutes of Health), Benjamin Mordmüller(Radboud University Nijmegen), Patrick E. Duffy(National Institute of Allergy and Infectious Diseases), B. Kim Lee Sim(Sanaria), Mei‐Chun Chen(National Yang Ming Chiao Tung University), Chris J. Janse(Leiden University Medical Center), Sean C. Murphy(University of Washington), Meta Roestenberg(Radboud University Medical Center), Eric R. James(Sanaria), Kirsten E. Lyke(University of Maryland, Baltimore), Ashley M. Vaughan(Infectious Disease Research Institute), Yonas Abebe(Sanaria), Robert W. Sauerwein(Radboud University Nijmegen), Peter F. Billingsley(Sanaria), Salim Abdulla(Ifakara Health Institute), Claudia Daubenberger(Swiss Tropical and Public Health Institute), Sumana Chakravarty(Sanaria), Sélidji Todagbé Agnandji(Universität Hamburg), Sara A. Healy(National Institutes of Health), Marcel Tanner(Swiss Tropical and Public Health Institute), David M. Cook, Joana C. Silva(J. Craig Venter Institute)
Cited by 46
Related Papers
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
|New England Journal of Medicine|2000|874
Macronuclear Genome Sequence of the Ciliate Tetrahymena thermophila, a Model Eukaryote
|PLoS Biology|2006|798
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
|The Lancet|2001|643
Trained immunity, tolerance, priming and differentiation: distinct immunological processes
|Nature Immunology|2020|591
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|536